Sex-Related Disparities in Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes and Heart Failure-Reference-Cited by-同舟云学术

Sex-Related Disparities in Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes and Heart Failure

Published:2023-11-01 Issue:11 Volume:32 Page:1219-1228
ISSN:1540-9996
Container-title:Journal of Women's Health
language:en
Short-container-title:Journal of Women's Health

Author:

Hammer Andreas¹,Hofer Felix¹,Kazem Niema¹,Koller Lorenz¹,Steinacher Eva¹,Baumer Ulrike¹,Wollmann Felix¹,Kautzky-Willer Alexandra²^ORCID,Beitl Klara³,Remer Franziska⁴,Hengstenberg Christian¹,Niessner Alexander¹,Sulzgruber Patrick¹

Affiliation:

1. Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

2. Division of Endocrinology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

3. Clinical Division of Gynecological Endocrinology and Reproductive Medicine, Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.

4. Department of Physical Medicine, Rehabilitation and Occupational Medicine, Medical University of Vienna, Vienna, Austria.

Publisher

Mary Ann Liebert Inc

Subject

General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/jwh.2023.0059

Reference37 articles.

1. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

2. Sex and gender differences in therapy of type 2 diabetes

3. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus

4. Diabetes and cardiovascular disease. The Framingham study

5. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials